The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction
Abstract
BACKGROUND: The pathophysiology of heart failure with normal ejection fraction (HFNEF) is still under discussion. Here we report the influence of cardiac inflammation on extracellular matrix (ECM) remodeling in patients with HFNEF. METHODS AND RESULTS: We investigated left ventricular systolic and diastolic function in 20 patients with HFNEF and 8 control patients by conductance catheter methods and echocardiography. Endomyocardial biopsy samples were also obtained, and ECM proteins as well as cardiac inflammatory cells were investigated. Primary human cardiac fibroblasts were outgrown from the endomyocardial biopsy samples to investigate the gene expression of ECM proteins after stimulation with transforming growth factor-β. Diastolic dysfunction was present in the HFNEF patients compared with the control patients. In endomyocardial biopsy samples from HFNEF patients, we found an accumulation of cardiac collagen, which was accompanied by a decrease in the major collagenase system (matrix metalloproteinase-1) in the heart. Moreover, a subset of inflammatory cells, which expressed the profibrotic growth factor transforming growth factor-β, could be documented in the HFNEF patients. Stimulation of primary human cardiac fibroblasts from HFNEF patients with transforming growth factor-β resulted in transdifferentiation of fibroblasts to myofibroblasts, which produced more collagen and decreased the amount of matrix metalloproteinase-1, the major collagenase in the human heart. A positive correlation between cardiac collagen, as well as the amount of inflammatory cells, and diastolic dysfunction was evident and suggests a direct influence of inflammation on fibrosis triggering diastolic dysfunction. CONCLUSIONS: Cardiac inflammation contributes to diastolic dysfunction in HFNEF by triggering the accumulation of ECM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The last two alterations are likely triggered by microvascular endothelial inflammation [70].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [70]
Citations
Cites
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,209
Paulus, W. J., Tschöpe, C., Sanderson, J. E., Rusconi, C., Flachskampf, F. A., Rademakers, F. E., Marino, P. N., Smiseth, O. A., Keulenaer, G. W. D., Leite-Moreira, A. F., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm037 · Cited by 2,646
Self-citationOutcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study
Bhatia, R. S., Tu, J. V., Lee, D. S., Austin, P. C., Fang, J., Haouzi, A., Gong, Y., & Liu, P. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051530 · Cited by 1,959
Zile, M. R., Baicu, C. F., & Gaasch, W. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032566 · Cited by 1,577
New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part I
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1102.105289 · Cited by 1,185
Spinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,139
Souders, C. A., Bowers, S., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 1,018
Spinale, F. G. (2002) · Circulation Research · doi:10.1161/01.res.0000013290.12884.a3 · Cited by 735
van Heerebeek, L., Hamdani, N., Handoko, M. L., Falcao-Pires, I., Musters, R. J., Kupreishvili, K., Ijsselmuiden, A. J. J., Schalkwijk, C. G., Bronzwaer, J. G. F., Diamant, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.728550 · Cited by 723
Borlaug, B. A., Melenovsky, V., Russell, S. D., Kessler, K., Pacak, K., Becker, L. C., & Kass, D. A. (2006) · Circulation · doi:10.1161/circulationaha.106.632745 · Cited by 699
Cited by
Sorted by citations
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
Self-citationPieske, B. M., Tschöpe, C., de Boer, R. A., Fraser, A. G., Anker, S. D., Donal, E., Edelmann, F., Fu, M. L. X., Guazzi, M., Lam, C. S. P., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz641 · Cited by 1,961
Self-citationPhenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap
Shah, S. J., Kitzman, D. W., Borlaug, B. A., van Heerebeek, L., Zile, M. R., Kass, D. A., & Paulus, W. J. (2016) · Circulation · doi:10.1161/circulationaha.116.021884 · Cited by 1,003
Mohammed, S. F., Hussain, S., Mirzoyev, S. A., Edwards, W. D., Maleszewski, J. J., & Redfield, M. M. (2015) · Circulation · doi:10.1161/circulationaha.114.009625 · Cited by 874
Atrial Fibrillation Begets Heart Failure and Vice Versa
Santhanakrishnan, R., Wang, N., Larson, M. G., Magnani, J. W., McManus, D. D., Lubitz, S. A., Ellinor, P. T., Cheng, S. C., Vasan, R. S., Lee, D. S., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.018614 · Cited by 874
Murphy, S., Kakkar, R. K., McCarthy, C. P., & Januzzi, J. L. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.014 · Cited by 791
Chronic Heart Failure and Inflammation
Dick, S. A., & Epelman, S. (2016) · Circulation Research · doi:10.1161/circresaha.116.308030 · Cited by 709
Myofibroblast-mediated mechanisms of pathological remodelling of the heart
Weber, K. T., Sun, Y., Bhattacharya, S. K., Ahokas, R. A., & Gerling, I. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.158 · Cited by 692
Franssen, C., Chen, H. S., Unger, A., Korkmaz, H. I., Keulenaer, G. W. D., Tschöpe, C., Leite-Moreira, A. F., Musters, R. J. P., Niessen, H. W. M., Linke, W. A., et al. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2015.10.007 · Cited by 615
Self-citationCrosstalk between fibroblasts and inflammatory cells
Linthout, S. V., Miteva, K., & Tschöpe, C. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu062 · Cited by 588
Self-citationHeart Failure With Preserved Ejection Fraction: Mechanisms, Clinical Features, and Therapies
Sharma, K., & Kass, D. A. (2014) · Circulation Research · doi:10.1161/circresaha.115.302922 · Cited by 508
Cardiac macrophages promote diastolic dysfunction
Hulsmans, M., Sager, H. B., Roh, J. D., Valero‐Muñoz, M., Houstis, N. E., Iwamoto, Y., Sun, Y., Wilson, R. M., Wojtkiewicz, G. R., Tricot, B., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171274 · Cited by 508
Inflammation – Cause or Consequence of Heart Failure or Both?
Linthout, S. V., & Tschöpe, C. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0337-9 · Cited by 484
Self-citationShah, S. J., Borlaug, B. A., Kitzman, D. W., McCulloch, A. D., Blaxall, B. C., Agarwal, R., Chirinos, J. A., Collins, S., Deo, R. C., Gladwin, M. T., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.041886 · Cited by 436
Cellular and molecular pathobiology of heart failure with preserved ejection fraction
Mishra, S., & Kass, D. A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00480-6 · Cited by 437
Pieske, B. M., Tschöpe, C., de Boer, R. A., Fraser, A. G., Anker, S. D., Donal, E., Edelmann, F., Fu, M. L. X., Guazzi, M., Lam, C. S. P., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1741 · Cited by 410
Self-citationMacrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Chen, R., Zhang, H., Tang, B., Luo, Y., Yang, Y., Zhong, X., Chen, S., Xu, X., Huang, S., & Liu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01840-1 · Cited by 418
Simmonds, S. J., Cuijpers, I., Heymans, S. R. B., & Jones, E. A. V. (2020) · Cells · doi:10.3390/cells9010242 · Cited by 399
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
López, B., Ravassa, S., Moreno, M. U., José, G. S., Beaumont, J., González, A., & Díez, J. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00504-1 · Cited by 383
Heart failure with preserved ejection fraction: from mechanisms to therapies
Lam, C. S. P., Voors, A. A., de Boer, R. A., Solomon, S. D., & van Veldhuisen, D. J. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy301 · Cited by 355
Inflammatory Cytokines in Heart Failure: Mediators and Markers
Gullestad, L. L., Ueland, T., Vinge, L. E., Finsen, A. V., Yndestad, A., & Aukrust, P. (2012) · Cardiology · doi:10.1159/000338166 · Cited by 355
Coronary Microvascular Dysfunction
Vancheri, F., Longo, G., Vancheri, S., & Henein, M. Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092880 · Cited by 354
Gutterman, D. D., Chabowski, D. S., Kadlec, A. O., Durand, M. J., Freed, J. K., Ait‐Aissa, K., & Beyer, A. (2016) · Circulation Research · doi:10.1161/circresaha.115.305364 · Cited by 336
Hahn, V. S., Yanek, L. R., Vaishnav, J., Ying, W., Vaidya, D. M., Lee, Y. J., Riley, S. J., Subramanya, V., Brown, E. E., Hopkins, C. D., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2020.04.007 · Cited by 325
Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction
Hahn, V. S., Petucci, C. J., Kim, M., Bedi, K. C., Wang, H., Mishra, S., Koleini, N., Yoo, E., Margulies, K. B., Arany, Z. P., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.061846 · Cited by 305
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction
Hahn, V. S., Knutsdottir, H., Luo, X., Bedi, K., Margulies, K. B., Haldar, S. M., Stolina, M., Yin, J., Khakoo, A. Y., Vaishnav, J., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050498 · Cited by 291
Metabolic inflammation in heart failure with preserved ejection fraction
Schiattarella, G. G., Rodolico, D., & Hill, J. A. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa217 · Cited by 284
Monocyte and macrophage contributions to cardiac remodeling
Hulsmans, M., Sam, F., & Nahrendorf, M. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.015 · Cited by 291
Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout
Hansildaar, R., Vedder, D., Baniaamam, M., Tausche, A.-K., Gerritsen, M., & Nurmohamed, M. T. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30221-6 · Cited by 278
Wijk, S. S., Tromp, J., Beussink‐Nelson, L., Hage, C., Svedlund, S., Saraste, A., Swat, S. A., Sanchez, C., Njoroge, J. N., Tan, R., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.045810 · Cited by 268
Livshits, G., & Kalinkovich, A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100980 · Cited by 245
VCAM-1 as a predictor biomarker in cardiovascular disease
Troncoso, M. F., Ortiz‐Quintero, J., Garrido‐Moreno, V., Sanhueza‐Olivares, F., Guerrero‐Moncayo, A., Chiong, M., Castro, P., Garcı́a, L., Gabrielli, L., Corbalan, R. L., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166170 · Cited by 233
Heart failure with preserved ejection fraction
Gladden, J. D., Linke, W. A., & Redfield, M. M. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1480-8 · Cited by 235
The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis
Murtha, L. A., Schuliga, M. J., Mabotuwana, N. S., Hardy, S. A., Waters, D. W., Burgess, J. K., Knight, D. A., & Boyle, A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00777 · Cited by 235
Biological Phenotypes of Heart Failure With Preserved Ejection Fraction
Lewis, G. A., Schelbert, E. B., Williams, S. G., Cunnington, C., Ahmed, F. Z., McDonagh, T. A., & Miller, C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.006 · Cited by 220
Myocardial Remodeling in Hypertension
González, A., Ravassa, S., López, B., Moreno, M. U., Beaumont, J., José, G. S., Querejeta, R., Bayés‐Genís, A., & Dı́ez, J. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11125 · Cited by 215
Deswal, A. M., Richardson, P. A., Bozkurt, B., & Mann, D. L. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.04.007 · Cited by 219
Sorop, O., HEINONEN, I. H. A., van Kranenburg, M., van de Wouw, J., de Beer, V. J., Nguyen, I., Octavia, Y., van Duin, R. W. B., Stam, K., van Geuns, R., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy038 · Cited by 213
Coronary microvascular dysfunction in hypertrophy and heart failure
Camici, P. G., Tschöpe, C., Carli, M. F. D., Rimoldi, O. E., & Linthout, S. V. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa023 · Cited by 217
Self-citationJuni, R. P., Kuster, D. W. D., Goebel, M., Helmes, M., Musters, R. J. P., van der Velden, J., Koolwijk, P., Paulus, W. J., & van Hinsbergh, V. W. M. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.04.003 · Cited by 208
Murdoch, C. E., Chaubey, S., Zeng, L., Yu, B., Ívetic, A., Walker, S. J., Vanhoutte, D., Heymans, S. R. B., Grieve, D., Cave, A. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.572 · Cited by 200
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
Sweeney, M., Corden, B., & Cook, S. A. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910865 · Cited by 202
Glezeva, N., & Baugh, J. A. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9405-8 · Cited by 194
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
Nagaraju, C. K., Robinson, E. L., Abdesselem, M., Trenson, S., Dries, E., Gilbert, G., Janssens, S. P., Cleemput, J. V., Rega, F., Meyns, B. P., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.049 · Cited by 187
Heart failure with preserved ejection fraction
HAMO, C. E., DeJong, C., Hartshorne‐Evans, N., Lund, L. H., Shah, S. J., Solomon, S. D., & Lam, C. S. P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00540-y · Cited by 197
Dyck, J. R. B., Sossalla, S. T., Hamdani, N., Coronel, R., Weber, N. C., Light, P. E., & Zuurbier, C. J. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.03.005 · Cited by 181
New Targets to Treat the Structural Remodeling of the Myocardium
González, A., Ravassa, S., Beaumont, J., López, B., & Dı́ez, J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.058 · Cited by 176
Hage, C., Michaëlsson, E., Linde, C. M., Donal, E., Daubert, J., Gan, L., & Lund, L. H. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.116.001633 · Cited by 174
Inspiration from heart development: Biomimetic development of functional human cardiac organoids
Richards, D. J., Coyle, R. C., Tan, Y., Jia, J., Wong, K., Toomer, K., Menick, D. R., & Mei, Y. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.021 · Cited by 166
Cardiac fibroblasts support cardiac inflammation in heart failure
Lindner, D., Zietsch, C., Tank, J., Sossalla, S. T., Fluschnik, N., Hinrichs, S., Maier, L. S., Poller, W. C., Blankenberg, S., Schultheiss, H., et al. (2014) · Basic Research in Cardiology · doi:10.1007/s00395-014-0428-7 · Cited by 162
Self-citationAlex, L., Russo, I., Holoborodko, V., & Frangogiannis, N. G. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00238.2018 · Cited by 162
Hummel, S. L., Seymour, E. M., Brook, R. D., Kolias, T. J., Sheth, S. S., Rosenblum, H. R., Wells, J. M., & Weder, A. B. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.202705 · Cited by 161
Mitochondrial DNA as an inflammatory mediator in cardiovascular diseases
Nakayama, H., & Otsu, K. (2018) · Biochemical Journal · doi:10.1042/bcj20170714 · Cited by 160
Kato, T., Chokshi, A. D., Singh, P., Khawaja, T., Cheema, F. H., Akashi, H., Shahzad, K., Iwata, S., Homma, S., Takayama, H., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.962142 · Cited by 158
Heart Failure With Preserved Ejection Fraction
Reddy, Y. N. V., & Borlaug, B. A. (2015) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2015.12.002 · Cited by 160
Glezeva, N., Voon, V., Watson, C. J., Horgan, S. J., McDonald, K., Ledwidge, M. T., & Baugh, J. A. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.11.004 · Cited by 152
Interleukin-18 as a Therapeutic Target in Acute Myocardial Infarction and Heart Failure
O’Brien, L. C., Mezzaroma, E., Tassell, B. W. V., Marchetti, C., Carbone, S., Abbate, A., & Toldo, S. A. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00034 · Cited by 151
Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
Wong, J. A., Conen, D., Gelder, I. C. V., McIntyre, W. F., Crijns, H. J. G. M., Wang, J., Gold, M. R., Hohnloser, S. H., Lau, C., Capucci, A., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.519 · Cited by 152
Heart Failure with Preserved Ejection Fraction: Uncertainties and Dilemmas
Ferrari, R., Böhm, M., Cleland, J. G. F., Paulus, W. J., Pieske, B. M., Rapezzi, C., & Tavazzi, L. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.304 · Cited by 150
Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction
Dryer, K., Gajjar, M. M., Narang, N., Lee, M., Paul, J., Shah, A. P., Nathan, S., Butler, J., Davidson, C. J., Fearon, W. F., et al. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00680.2017 · Cited by 146
High-sensitivity C-reactive protein in heart failure with preserved ejection fraction
DuBrock, H. M., AbouEzzeddine, O. F., & Redfield, M. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201836 · Cited by 144
Ntsekhe, M., & Baker, J. V. (2022) · Circulation · doi:10.1161/circulationaha.122.057443 · Cited by 144
Cardiac metabolism in HFpEF: from fuel to signalling
Capone, F., Sotomayor-Flores, C., Bode, D., Wang, R., Rodolico, D., Strocchi, S., & Schiattarella, G. G. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac166 · Cited by 145
CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells
Feng, G., Bajpai, G., Ma, P., Koenig, A. L., Bredemeyer, A. L., Lokshina, I., Lai, L., Förster, I., Leuschner, F., Kreisel, D., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.055888 · Cited by 143
Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities
Cuijpers, I., Simmonds, S. J., van Bilsen, M., Czarnowska, E., González, A., Heymans, S. R. B., Kuhn, A.-R., Mulder, P. G. H., Ratajska, A., Jones, E. A. V., et al. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-0798-y · Cited by 144
Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
D’Amario, D., Migliaro, S., Borovac, J. A., Restivo, A., Vergallo, R., Galli, M., Leone, A. M., Montone, R. A., Niccoli, G., Aspromonte, N., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01347 · Cited by 138
Heart Failure With Preserved Ejection Fraction: A Review of Cardiac and Noncardiac Pathophysiology
Gevaert, A. B., Boen, J. R. A., Segers, V. F. M., & Craenenbroeck, E. M. V. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00638 · Cited by 140
Pyroptosis: A New Regulating Mechanism in Cardiovascular Disease
Ji, N., Qi, Z., Wang, Y., Yang, X., Yan, Z., Li, M., Ge, Q., & Zhang, J. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s308177 · Cited by 135
Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?
López, B., González, A., Lindner, D., Westermann, D., Ravassa, S., Beaumont, J., Gallego, I., Zudaire, A., Brugnolaro, C., Querejeta, R., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt100 · Cited by 132
Self-citationImmunometabolic mechanisms of heart failure with preserved ejection fraction
Schiattarella, G. G., Alcaide, P., Condorelli, G., Gillette, T. G., Heymans, S. R. B., Jones, E. A. V., Kallikourdis, M., Lichtman, A. H., Marelli‐Berg, F. M., Shah, S. J., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00032-w · Cited by 137
The Role of Inflammation in Cardiovascular Outcome
Montecucco, F., Liberale, L., Bonaventura, A., Vecchié, A., Dallegri, F., & Carbone, F. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0646-1 · Cited by 133
Macrophages and Cardiovascular Health
Frodermann, V., & Nahrendorf, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00068.2017 · Cited by 128
An, N., Gao, Y., Si, Z., Zhang, H., Wang, L., Tian, C., Yuan, M., Yang, X., Li, X., Shang, H., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01592 · Cited by 124
Sex-Related Differences in the Extent of Myocardial Fibrosis in Patients With Aortic Valve Stenosis
Tastet, L. L., Kwieciński, J., Pîbarot, P., Capoulade, R., Everett, R. J., Newby, D. E., Shen, M., Guzzetti, E., Arsenault, M., Bédard, É., et al. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.06.014 · Cited by 124
Molecular and Cellular Basis for Diastolic Dysfunction
van Heerebeek, L., Franssen, C., Hamdani, N., Verheugt, F. W. A., Somsen, G. A., & Paulus, W. J. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0109-5 · Cited by 123
Paulus, W. J., & Canto, E. D. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.07.012 · Cited by 127
Role of Monocytes in Heart Failure and Atrial Fibrillation
Shahid, F., Lip, G. Y. H., & Shantsila, E. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007849 · Cited by 124
Khattak, H. K., Hayat, F., Pamboukian, S. V., Hahn, H. S., Schwartz, B. P., & Stein, P. K. (2018) · Texas Heart Institute Journal · doi:10.14503/thij-15-5678 · Cited by 118
ZBP1 Protects Against mtDNA-Induced Myocardial Inflammation in Failing Hearts
Enzan, N., Matsushima, S., Ikeda, S., Okabe, K., Ishikita, A., Yamamoto, T., Sada, M., Miyake, R., Tsutsui, Y., Nishimura, R., et al. (2023) · Circulation Research · doi:10.1161/circresaha.122.322227 · Cited by 121
Gallet, R., de Couto, G., Simsolo, E., Valle, J., Sun, B., Liu, W., Tseliou, E., Zile, M. R., & Marbán, E. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.01.003 · Cited by 121
Chronic low‐grade inflammation in heart failure with preserved ejection fraction
Mesquita, T., Lin, Y., & Ibrahim, A. G.-E. (2021) · Aging Cell · doi:10.1111/acel.13453 · Cited by 118
Heart Failure With Preserved Ejection Fraction
Udelson, J. E. (2011) · Circulation · doi:10.1161/circulationaha.111.071696 · Cited by 114
Extracellular Matrix Communication and Turnover in Cardiac Physiology and Pathology
Takawale, A. R., Sakamuri, S. S. V. P., & Kassiri, Z. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140045 · Cited by 115
Stavrakis, S., Elkholey, K., Morris, L. M., Niewiadomska, M., Asad, Z. U. A., & Humphrey, M. B. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023582 · Cited by 111
Engebretsen, K. V. T., Skårdal, K., Bjørnstad, S., Marstein, H. S., Skrbic, B., Sjaastad, I., Christensen, G., Bjørnstad, J. L., & Tønnessen, T. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.08.008 · Cited by 110
Macrophages in Heart Failure with Reduced versus Preserved Ejection Fraction
DeBerge, M., Shah, S. J., Wilsbacher, L. D., & Thorp, E. B. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.01.002 · Cited by 110
da Silva, D. M., Langer, H. F., & Graf, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092322 · Cited by 108
Myocardial T1 mapping: modalities and clinical applications.
Jellis, C. L., & Kwon, D. H. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-3652.2013.09.03 · Cited by 105
ROS signalling between endothelial cells and cardiac cells
Zhang, M., & Shah, A. M. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu050 · Cited by 105
Autophagy and oxidative stress in non-communicable diseases: A matter of the inflammatory state?
Peña‐Oyarzún, D., Bravo, R., Díaz‐Vegas, A., Aleman, L., Chiong, M., García, L., Claudia Bambs, S., Troncoso, R., Cifuentes, M., Morselli, E., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.084 · Cited by 108
Understanding heart failure with preserved ejection fraction: where are we today?
van Heerebeek, L., & Paulus, W. J. (2016) · Netherlands Heart Journal · doi:10.1007/s12471-016-0810-1 · Cited by 97
Warbrick, I., & Rabkin, S. W. (2019) · Obesity Reviews · doi:10.1111/obr.12828 · Cited by 100
Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease
Peters, L. J. F., Biessen, E. A. L., Hohl, M., Weber, C., van der Vorst, E. P. C., & Santovito, D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00793 · Cited by 101
Pezel, T., Viallon, M., Croisille, P., Sebbag, L., Bochaton, T., Garot, J., Lima, J. A. C., & Mewton, N. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.05.036 · Cited by 97
Reversible and irreversible differentiation of cardiac fibroblasts
Driesen, R. B., Nagaraju, C. K., Abi-Char, J., Coenen, T., Lijnen, P. J., Fagard, R. H., Sipido, K. R., & Petrov, V. V. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt338 · Cited by 97
Westermann, D., Savvatis, K., Lindner, D., Zietsch, C., Becher, P. M., Hammer, E., Heimesaat, M. M., Bereswill, S., Völker, U., Escher, F., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.035964 · Cited by 95
Self-citationvan de Wouw, J., Broekhuizen, M., Sorop, O., Joles, J. A., Verhaar, M. C., Duncker, D. J., Danser, A. H. J., & Merkus, D. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01108 · Cited by 97
New Insights in (Inter)Cellular Mechanisms by Heart Failure with Preserved Ejection Fraction
Tschöpe, C., & Linthout, S. V. (2014) · Current Heart Failure Reports · doi:10.1007/s11897-014-0219-3 · Cited by 97
Self-citationCardiac metabolism — A promising therapeutic target for heart failure
Noordali, H., Loudon, B. L., Frenneaux, M. P., & Madhani, M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.001 · Cited by 94
Florijn, B. W., Bijkerk, R., van der Veer, E. P., & van Zonneveld, A. J. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx223 · Cited by 95
Metadata
- Authors
- Westermann, D., Lindner, D., Kasner, M., Zietsch, C., Savvatis, K., Escher, F., von Schlippenbach, J., Skurk, C., Steendijk, P., Riad, A., Poller, W., Schultheiss, H.-P., & Tschöpe, C.
- Affiliations
- Leiden University Medical Center (NL)
- From the Department of Cardiology and Pneumology (D.W., D.L., M.K., C.Z., K.S., F.E., J.v.S., C.S., A.R., W.P., H.-P.S., C.T.), Charité, Universititäts-Medizin Berlin, Campus Benjamin Franklin, Berlin, Germany, and Department of Cardiology (P.S.), Leiden University Medical Center, Leiden, The Netherlands.
- ORCID
- Venue
- Circulation Heart Failure
- Published
- 2011-01
- Volume
- 4
- Issue
- 1
- Pages
- 44-52
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2131184290
- Cited by
- 644
- References
- 55
- Citations by year
- 2026: 32 · 2025: 48 · 2024: 53 · 2023: 50 · 2022: 57 · 2021: 58 · 2020: 49 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 35 · 2015: 42 · 2014: 30 · 2013: 21 · 2012: 17
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Heart Failure (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- heart failure with preserved ejection fraction, cardiac inflammation, extracellular matrix remodeling, diastolic dysfunction, myocardial fibrosis, collagen deposition, MMP-1, TGF-beta, myofibroblasts, endomyocardial biopsy, left ventricular systolic function
- MeSH terms
- Adult, Aged, Biopsy, Cells, Cultured, Collagen, Extracellular Matrix, Female, Fibroblasts, Fibrosis, Heart, Heart Failure, Humans, Inflammation, Male, Middle Aged, Myocardium, Stroke Volume, Case-Control Studies, Transforming Growth Factor beta, Ventricular Function, Left, Extracellular Matrix Proteins, Disease Progression, Matrix Metalloproteinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review